You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 7, July 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ataxia
 •Neurogenetics
 •Neurology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Mitochondrial Complex I Gene Variant Associated With Early Age at Onset in Spinocerebellar Ataxia Type 2

David K. Simon, MD, PhD; Kangni Zheng, MD; Luis Velázquez, MD, PhD; Nieves Santos, MD; Luis Almaguer, MD; K. Pattie Figueroa, MS; Stefan-M. Pulst, MD

Arch Neurol. 2007;64(7):1042-1044.

Background  A common mitochondrial complex I gene polymorphism (10398G) is reported to be inversely associated with the risk of Parkinson disease. We hypothesized that this variant might have a protective effect on the central nervous system and therefore might delay the onset of symptoms in spinocerebellar ataxia type 2 (SCA2).

Objective  To assess the association of the 10398G polymorphism with age at onset in Cuban patients with SCA2.

Design  Genetic association study.

Setting  Holguin, Cuba.

Patients  Forty-six Cuban patients with SCA2.

Main Outcome Measures  Presence or absence of the 10398G polymorphism was determined in 46 Cuban patients with SCA2 and early or late onset of symptoms, defined as at least 2 SDs lower than or higher than the mean age at onset for patients with a similarly sized triplet repeat expansion.

Results  The polymorphism was present in 11 of 27 Cuban patients with SCA2 and early onset (41%) vs 2 of 19 with late onset (11%) (Fisher exact test; P = .04).

Conclusion  Contrary to our prediction of a later onset of SCA2 in patients with the 10398G polymorphism, we find that this variant is associated with an earlier age at onset in Cuban patients with SCA2.


Author Affiliations: Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts (Drs Simon and Zheng); Clinica para la Investigacion y Rehabilitacion de las Ataxias Hereditarias, Holguin City, Cuba (Drs Velázquez, Santos, and Almaguer); and Division of Neurology, Cedars-Sinai Medical Center (Dr Figueroa), and Departments of Medicine and Neurobiology, David Geffen School of Medicine at UCLA (Dr Pulst), Los Angeles, California.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.